New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 30, 2014
18:37 EDTMDT, EWEdwards' Sapien XT outperforms Medtronic’s CoreValve, Bloomberg reports
Edwards Lifesciences' (EW) second-generation heart valve, that can be inserted without open-heart surgery, was found to outperform Medtronic’s (MDT) device in a head-to-head comparison, says Bloomberg. Researchers said the newest form of Edwards’ device, the Sapien XT, had about the same death rate as CoreValve and was easier to insert, added Bloomberg. Reference Link
News For EW;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
07:10 EDTMDTMedtronic study detects gene associated with sudden cardiac death
Subscribe for More Information
August 25, 2015
09:07 EDTMDTMedtronic to acquire Twelve for $458M
In support of the company's therapy innovation strategy, Medtronic announced that it has signed a definitive agreement to acquire Twelve, a medical device company focused on the development of a transcatheter mitral valve replacement, or TMVR device. Twelve is the twelfth company spun out from the premier medical device incubator The Foundry. Medtronic has agreed to pay up to $458M for Twelve including $408M at closing and $50M on achievement of CE Marking. The cash- and debt-free transaction remains subject to customary closing conditions, and is expected to close in October 2015.
August 24, 2015
08:29 EDTEWWilliam Blair to hold a field trip
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use